Lybrel Articles
Wyeth's Lybrel now on sale in USA
6 August 2007
Wyeth's 2nd-qtr net income climbs 12.5%
30 July 2007
Poland
11 June 2007
Wyeth's Lybrel approved by FDA
28 May 2007
Wyeth unveils seven late-stage drugs for 11 indications at its annual R&D presentation
16 October 2006
Wyeth's revenues hit $5.2B for 1st-half 2006
31 July 2006
Lybrel receives an FDA approvable letter
10 July 2006
ACOG: Strong data on Wyeth's Lybrel
15 May 2006
Wyeth's 1st-qtr 2006 revenues $4.8B, up 6%
1 May 2006
Showing 1-9 of 9 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
